A cutting-edge liquid biopsy product that analyzes circulating tumor DNA (ctDNA) to identify somatic mutations. It aids in treatment selection, response monitoring, and recurrence detection for optimal cancer care.
Manufactured by
Seongnam-si, Gyeonggi-do, South Korea
Dxome Co., Ltd. is a molecular diagnostics company specializing in next-generation sequencing (NGS)–based solutions with a strong focus on liquid biopsy. By analyzing circulating tumor DNA (ctDNA) and hereditary mutations from a simple blood sample, Dxome enables early cancer detection, treatment selection, therapy monitoring, and recurrence detection with exceptional sensitivity and accuracy. Its integrated approach—combining proprietary reagents, advanced sequencing panels, bioinformatics pipelines, and clinical reporting—has led to innovative products such as DxLiquid Pan100 and DxLiquid TMB500 , which reduce the need for invasive tissue biopsies and support personalized medicine. Guided by its mission to deliver precise insights that improve patient outcomes, Dxome continues to invest in R D, pursue global certifications including CLIA accreditation, and collaborate with hospitals and research institutions worldwide, positioning itself as a trusted leader in precision diagnostics for cancer and genetic diseases.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Biopsense Oy
Finland · 4 relevant products
GENETRON HEALTH (BEIJING) CO., LTD
China · 3 relevant products
NOROVA
China · 4 relevant products
Burning Rock Dx Co. Ltd.
China · 3 relevant products
guangzhou biotron technolongy co.,ltd
China · 5 relevant products
GeneCker Co., Ltd.
South Korea · 3 relevant products
Eone-Diagnomics Genome Center
South Korea · 2 relevant products
Bio-Techne Diagnostics
United States · 3 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 3 relevant products
HLB PANAGENE Co., Ltd.
South Korea · 1 relevant product
37 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 84 closest product alternatives
Biopsense Oy · Finland
Liquid biopsy diagnostic solution for non-invasive cancer monitoring and treatment personalization through cell-free DNA analysis. Automates plasma separation, DNA extraction, and quantitation to reduce pre-analytical variability and enable frequent patient monitoring for improved treatment response assessment.
GENETRON HEALTH (BEIJING) CO., LTD · China
Molecular diagnostic test utilizing circulating tumor DNA and biomarkers from blood samples. Enables non-invasive cancer screening and early detection. Supports monitoring of treatment response and recurrence in cancer patients.
NOROVA · China
Precision diagnostic service utilizing liquid biopsy technology for early detection and monitoring of malignant tumors. Analyzes circulating biomarkers from patient blood samples. Enables non-invasive assessment of tumor characteristics and treatment response.
Burning Rock Dx Co. Ltd. · China
Circulating tumor DNA detection and analysis system for cancer diagnosis and monitoring. Enables early cancer detection through blood-based liquid biopsy technology with high sensitivity and specificity.
guangzhou biotron technolongy co.,ltd · China
Advanced liquid biopsy system for non-invasive detection and analysis of circulating tumor markers, circulating tumor cells, and cell-free DNA from blood samples.
NOROVA · China
An independently developed platform for detecting circulating tumor DNA with high sensitivity and specificity compared to traditional detection methods. This liquid biopsy approach enables non-invasive, painless diagnosis through a single blood sample for comprehensive cancer patient support.
NOROVA · China
A diagnostic service utilizing independently developed CTC (circulating tumor cells) and ctDNA (circulating tumor DNA) detection platforms with high sensitivity and specificity. Compared to traditional detection methods, it can identify more disease information to achieve individualized precision therapy for tumor patients. Liquid biopsy is minimally invasive and painless, providing comprehensive tumor-related information from a single blood sample, offering strong support for malignant tumor diagnosis and treatment as a complement to traditional tissue biopsy.
GeneCker Co., Ltd. · South Korea
Integrated platform for cancer diagnosis utilizing liquid biopsy techniques with CRISPR/Cas9 technology. Includes complete workflow from sample collection through DNA sequencing to result analysis.
Eone-Diagnomics Genome Center · South Korea
Blood-based diagnostic testing methodology for non-invasive detection of genetic abnormalities and disease markers. Uses advanced sequencing techniques to analyze circulating DNA and genetic material.
Bio-Techne Diagnostics · United States
Advanced molecular assays for liquid biopsy applications enabling non-invasive detection of circulating biomarkers. Integrated with automated analysis for scalable clinical implementation.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A liquid biopsy-based test utilizing DNA methylation markers for post-treatment cancer recurrence monitoring and surveillance. Enables early detection of disease relapse and progression.
HLB PANAGENE Co., Ltd. · South Korea
A liquid biopsy diagnostic test for detection of EGFR mutations in circulating tumor DNA, supporting non-invasive lung cancer monitoring and treatment selection.
72 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products